Neuroimmune modulation represents a promising treatment strategy that uses vagus nerve stimulation to reduce inflammation in ...

The EMA has approved Cullinan Therapeutics’ clinical trial application for CLN-978, a drug intended to treat rheumatoid ...

The global rheumatoid arthritis drugs market was valued at $57,929 million in 2019, and is projected to reach $62,935 million by 2027, registering a CAGR of 2.8% from 2020 to 2027. Alarming rise in ...

Patients were in their early 50s on average, and some 80% were women. Nearly all were white (most participants were from ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

The Rheumatoid Arthritis Drugs/Therapeutics market revenue was $$ Million USD in 2022, grew to $$ Million USD in 2024, and will reach $$ Million USD in 2032, with a CAGR of $% during 2024-2032.

A new drug could dramatically ease the pain and misery of the 60,000 people in the UK who suffer from rheumatoid arthritis. Specialists believe that the drug, Remicade, is a major breakthrough in ...

Having psoriasis raises your risk of psoriatic arthritis — and rheumatoid arthritis, too. Make sure you can tell these two forms of arthritis apart.

A Texan drug compounder cannot rely on federal law to avoid a lawsuit over copycat sales of a rheumatoid arthritis treatment, ...

It is currently being evaluated for the treatment of systemic lupus erythematosus ... "Cullinan Therapeutics receives EMA approval for rheumatoid arthritis drug trial" was originally created ...